Janssen, K <br/><br/>
Apoptin is modified by SUMO conjugation and targeted to promyelocytic leukemia protein nuclear bodies.  [electronic resource] 

 -  Oncogene  Mar 2007 
 - 1557-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0950-9232 
<br/><br/><label>Standard No.: </label>10.1038/sj.onc.1209923  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Capsid Proteins--metabolism<br/>Cell Line<br/>Cell Line, Tumor<br/>Cell Nucleus--metabolism<br/>Fluorescent Antibody Technique<br/>Humans<br/>Immunoprecipitation<br/>Neoplasm Proteins--metabolism<br/>Nuclear Proteins--metabolism<br/>Promyelocytic Leukemia Protein<br/>SUMO-1 Protein--metabolism<br/>Transcription Factors--metabolism<br/>Tumor Suppressor Proteins--metabolism